Based on the regulation of Cav1 expression in hepatocytes in vitro [60] and in vivo upon NAFLD development [61], Cav1 serves as a crucial regulator of TGF-β signaling and thus TGF-β-related phenotypes. The gene discussed is TGFB1; the disease is metabolic dysfunction-associated steatotic liver disease.